MiscellaneousUtility of Waist-To-Height Ratio in Detecting Central Obesity and Related Adverse Cardiovascular Risk Profile Among Normal Weight Younger Adults (from the Bogalusa Heart Study)
Section snippets
Methods
The Bogalusa Heart Study is a biracial (65% white, 35% black) community-based study of the natural history of cardiovascular disease since childhood.5 The present study sample was derived from a cohort of 2,065 subjects (70% white and 42% men) 20 to 44 years old who were examined as a part of a longitudinal follow-up survey. The participants (n = 639) with a body mass index of 18.5 to 24.9 kg/m2 were considered of normal weight and included in the present study. Using the previously recommended
Results
As listed in Table 1, the normal weight subjects (n = 639) constituted 30.9% of the total cohort. Of these, 65 normal weight subjects (10.2%) had central obesity (waist-to-height ratio ≥0.5). The central obesity normal weight group, in addition to being relatively older, had significantly more men than women, and, after adjusting for age, race, and gender, had greater levels of diastolic blood pressure, mean arterial pressure, low-density lipoprotein cholesterol, triglycerides,
Discussion
The present community-based study used the waist-to-height ratio as a simple anthropometric measure of central (visceral) obesity in normal weight persons and found that normal weight subjects with central obesity were characterized by an increased mean arterial pressure, triglyceride/HDL cholesterol ratio, insulin resistance as shown by the HOMA-IR, and CRP compared to normal weight persons without central obesity. In addition, they had an excess carotid intima-media thickness, a validated
Acknowledgment
The Bogalusa Heart Study was a joint effort of many investigators and staff members whose contributions are gratefully acknowledged. We especially thank the study participants.
References (25)
- et al.
The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women
Prev Med
(2005) - et al.
Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups
Nutrition
(2005) - et al.
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
Am J Cardiol
(2005) - et al.
Hazards of obesity—the Framingham experience
Acta Med Scand
(1988) - et al.
Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors
Int J Obes
(2006) The Bogalusa Heart Study 20th anniversary symposium
Am J Med Sci
(1995)- et al.
Serum lipoproteins in children and methods for study
- et al.
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
Diabetologia
(1985) - et al.
Metabolic and behavioral characteristics of metabolically obese but normal-weight women
J Clin Endocrinol Metab
(2004) - et al.
High-resolution B-mode ultrasound scanning methods in the atherosclerosis risk in communities (ARIC) cohort
J Neuroimaging
(1991)
Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1993
Am J Epidemiol
Intima-media thickness: a tool for atherosclerosis imaging and event prediction
Am J Cardiol
Cited by (83)
Predicting the risk of type 2 diabetes through anthropometric indices in Pakistani adults- A sub-analysis of second National diabetes survey of Pakistan 2016–2017 (NDSP-07)
2021, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsLow socioeconomic status aggravated associations of exposure to mixture of air pollutants with obesity in rural Chinese adults: A cross-sectional study
2021, Environmental ResearchCitation Excerpt :Participants with a BMI <28.0 kg/m2, a WC < 90 cm for males and <80 cm for females, a WHR <0.9 for males and 0.85 for females, a WHtR <0.50, a BFP <25% for males and <30% for females, a VFI <10 were defined as no-obesity. ( International Diabetes Federation, 2006; Minematsu et al., 2011; Oh et al., 2018; Srinivasan et al., 2009; Working Group on Obesity in China, 2004; World Health Organization, 2008). The directed acyclic graphs (DAGs) were used to select the confounders (Greenland et al., 1999), thus the variables of gender and age selected by DAGs (as shown in Figure S2) were included in the final analysis.
Distinct phenotypic characteristics of normal-weight adults at risk of developing cardiovascular and metabolic diseases
2020, American Journal of Clinical NutritionAssociation between long-term exposure to ambient air pollution and obesity in a Chinese rural population: The Henan Rural Cohort Study
2020, Environmental PollutionCitation Excerpt :WC was used to measure the magnitude of the accumulation of fat in the abdomen, but WC may over- or underestimate risk for tall or short individuals with similar WC (International Diabetes Federation, 2006; Ononamadu et al., 2017). WHR and WHtR were other proxies of central obesity that correct the hip or height of an individual, but WHR and WHtR didn’t distinguish the subcutaneous or visceral fat (Ononamadu et al., 2017; Srinivasan et al., 2009; World Health Organization, 2008). BFP was estimated as the percentage of body fat in the body weight, without helping in distinguishing between subcutaneous and visceral fat mass (Minematsu et al., 2011).
Waist-height ratio: How well does it predict glucose intolerance and systemic hypertension?
2019, Diabetes Research and Clinical PracticeCitation Excerpt :They further stressed that due to the inclusion of height into the index, any potential confounding of cardio-metabolic risk by height is avoided. In a similar vein, WHtR has been shown to denote cardio-metabolic risk among individuals who are not obese according to other anthropometric indices. [7–11] Li et al. [8] reported that WHtR was a greater predictor of diabetes, hypertension, and dyslipidaemia compared to BMI or WC.
This study was supported by Grant AG-16592 from the National Institute on Aging, Bethesda, Maryland, and Grants 0855082E and 0555168B from the American Heart Association, Dallas, Texas.